e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Murine models of lung immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of type I and III interferons in experimental allergic asthma and after dsRNA-induced exacerbation
I. Mahmutovic Persson, H. Akbarshahi, A. Brandelius, L. Uller (Lund, Sweden)
Source:
Annual Congress 2013 –Murine models of lung immunology
Session:
Murine models of lung immunology
Session type:
Poster Discussion
Number:
1581
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Mahmutovic Persson, H. Akbarshahi, A. Brandelius, L. Uller (Lund, Sweden). Expression of type I and III interferons in experimental allergic asthma and after dsRNA-induced exacerbation. Eur Respir J 2013; 42: Suppl. 57, 1581
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Adjuvant-free mouse model of allergic asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Dose-dependent differential effects of thrombin in allergic bronchial asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
The immunomodulatory activity of protein S protects against allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Crucial timing of a viral component exposure to exacerbate allergen-induced asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Oral administration of saccharomyces cerevisiae inhibits the allergic airway response in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Immunomodulatory role of IL-37 in asthma pathogenesis
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Characterisation of a steroid-insensitive severe asthma model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
GARP reduces inflammation in a humanized mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe exacerbation of experimental asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept